{"id":"W2789592353","doi":"10.1158/1538-7445.sabcs17-p1-13-01","title":"Abstract P1-13-01: Duration of adjuvant trastuzumab in HER-2 positive breast cancer: Pooled results of overall, and disease-free survivals from meta-analyses of randomized controlled trials","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Trastuzumab; Internal medicine; Hazard ratio; Breast cancer; Meta-analysis; Oncology; Randomized controlled trial; Confidence interval; Odds ratio; Adjuvant; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03724026,0.005696109,0.02655091,0.008749208,0.0005184415,0.006552763,0.003062066,0.004046774,0.01034465],"category_scores_gemma":[0.08893333,0.002007442,0.0760498,0.007857691,0.001179205,0.003306149,0.002712006,0.004402622,0.001028533],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002607685,"about_ca_system_score_gemma":0.002754649,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002735706,"about_ca_topic_score_gemma":0.004767481,"domain_scores_codex":[0.9658155,0.02126412,0.007024462,0.00252079,0.002872441,0.0005026138],"domain_scores_gemma":[0.9403484,0.04581605,0.008774849,0.001772791,0.002694456,0.0005934217],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.004860991,0.00002097946,0.001244374,0.1800862,0.8075814,0.00009052135,0.00003359155,0.0006132767,0.0002234489,0.0001109678,0.0008791261,0.004255183],"study_design_scores_gemma":[0.002825369,0.0002551645,0.00177746,0.009654032,0.9834787,0.00007129299,0.00002431468,0.0003421764,0.00011538,0.0003440933,0.001085051,0.00002699093],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.01791396,0.9616373,0.006052988,0.001340112,0.001663822,0.003451277,0.006370309,0.0003737369,0.00119658],"genre_scores_gemma":[0.5035663,0.4464496,0.01680551,0.004282096,0.002409278,0.01427963,0.008898055,0.0004744199,0.002835165],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.03724026,"threshold_uncertainty_score":0.1969476,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1154351797078969,"score_gpt":0.4312703495841351,"score_spread":0.3158351698762382,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}